Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

O2.1 The course of health-related quality of life from diagnosis to two years follow-up in patients with oropharyngeal cancer: does HPV status matter?

Autor: Korsten, L., Jansen, F., Lissenberg-Witte, B., Vergeer, M., Brakenhoff, R., Leemans, R., Verdonck-de Leeuw, I.

Publikováno v: In Oral Oncology November 2022 134 Supplement

O4.2 Early detection of recurrent HPV-positive HNSCC by ctDNA analysis

Autor: Pierik, A., Poell, J., Brink, A., Leemans, R., Brakenhoff, R.

Publikováno v: In Oral Oncology November 2022 134 Supplement

Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource.

Autor: Nguyen HT; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Tang W; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Webster ALH; Laboratory of Genome Maintenance, Rockefeller University, New York, New York, USA., Whiteaker JR; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA., Chandler CM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Errazquin R; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medio-ambientales y Tecnológicas), Madrid, Spain., Roohollahi K; Amsterdam University Medical Center, Amsterdam, The Netherlands., Fritzke M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Hoskins EE; Amsterdam University Medical Center, Amsterdam, The Netherlands., Jonlin E; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; University of Washington Institute for Stem Cell and Regenerative Medicine, Seattle, Washington, USA., Wakefield L; Departments of Pediatrics and Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon, USA., Sullivan LB; Fred Hutchinson Cancer Center, Human Biology Division, Seattle, Washington, USA., Chen EY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA., Dorsman J; Amsterdam University Medical Center, Amsterdam, The Netherlands., Brakenhoff R; Amsterdam University Medical Center, Amsterdam, The Netherlands., Paulovich AG; Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, Washington, USA., Grompe M; Departments of Pediatrics and Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, Oregon, USA., Garcia-Escudero R; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Biomedical Oncology Unit, CIEMAT (Centro de Investigaciones Energéticas, Medio-ambientales y Tecnológicas), Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Wells SI; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Smogorzewska A; Laboratory of Genome Maintenance, Rockefeller University, New York, New York, USA., Monnat RJ Jr; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.; Department of Genome Sciences, University of Washington, Seattle, Washington, USA.

Publikováno v: International journal of cancer [Int J Cancer] 2023 Jul 01; Vol. 153 (1), pp. 183-196. Date of Electronic Publication: 2023 Mar 30.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.